CTOs on the Move

City of Winston-Salem, NC

www.cityofws.org

 
City of Winston-Salem, North Carolina, U.S.A. Local government. Contact City Link call 311; citylink@cityofws.org
  • Number of Employees: 250-1000
  • Annual Revenue: $100-250 Million
  • www.cityofws.org
  • 101, North Main Street
    Winston-Salem, NC USA 27101
  • Phone: 336.727.2063

Executives

Name Title Contact Details

Similar Companies

Swish Dental

SWISH Dental, with convenient throughout Austin, Texas, transforms the way dental care is done. SWISH is the premier practice for Austin dental care providing general, ortho, cosmetic, and family dentistry. Kick back, unwind, and experience complete co...

M and S Technologies

M and S Technologies is a Skokie, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Maxor

Maxor is a leading pharmacy care solutions company dedicated to improving patient outcomes and lowering the total cost of care through our clinically integrated set of pharmacy care services. Our teams help optimize the pharmacy experience for patients, our customers, their employees, and members whether it`s through our customized pharmacy benefit offerings; providing access to prescription medications and therapies through our home delivery and specialty pharmacies; or delivering clinical and financial value with our end-to-end pharmacy management solutions. With a legacy of exceptional service and deep clinical and pharmacy expertise, Maxor has been a trusted partner enabling pharmacy care since 1926.

Fitzgerald Industries International

Fitzgerald Industries International is a Acton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Celator Pharmaceuticals

Celator Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that is transforming the science of combination therapy and developing products to improve outcomes for patients with cancer. The Company is working to establish a new treatment paradigm in which rationally-designed, fully-integrated combination products replace combination regimens of individual agents. Celator`s proprietary technology platform, CombiPlex®, identifies the most effective synergistic ratio of the component drugs, optimizes the pharmacology of the drug combination prior to human clinical trials, allows simultaneous administration of the components as a single product and maintains the synergistic ratio of the components after administration thereby exposing tumor cells to the right amounts of drug for the right length of time.